Ifosfamide
- Product NDC
- 63323-142
- 11-digit product format
- 633230142
- Labeler code
- 63323
- Product ID
- 63323-142_8f166a04-4395-4ea1-8eda-98274f1bfec3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- IFOSFAMIDE
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- ANDA076078
- Marketing category
- ANDA
- Marketing start
- 2003-01-28
- Substance
- IFOSFAMIDE
- Active strength
- 1 g/1
- Pharmacologic classes
- Alkylating Activity [MoA], Alkylating Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ifosfamide
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| IFOSFAMIDE | 1 g/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | UM20QQM95Y |
| Rxcui | 1791593 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63323-142-10 | Ifosfamide | 1 in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 1 | | 5 |
| 63323-142-10 | Ifosfamide | 1 in 1 BOX | INJECTION, POWDER, LYOPHILIZED, | 1 | | 5 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| IFOSFAMIDE | ACTIVE INGREDIENT | UM20QQM95Y | IFOSFAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| IFOSFAMIDE | ACTIVE INGREDIENT | UM20QQM95Y | IFOSFAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| IFOSFAMIDE | ACTIVE MOIETY | UM20QQM95Y | IFOSFAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| IFOSFAMIDE | ACTIVE MOIETY | UM20QQM95Y | IFOSFAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | IFOSFAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | IFOSFAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63323-142 | IFOSFAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 4 | Current NDC, Legacy NDC, 2 package rows | 20241019_a311a947-7b78-4226-bfe0-f4aa0be20e27.zip |
| 63323-142 | IFOSFAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 3 | Current NDC, Legacy NDC | 20241019_fb7f49af-ffe9-4969-a69c-8ed14dd0616b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63323-142-10 | 63323014210 | 1 VIAL, SINGLE-DOSE in 1 BOX (63323-142-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE | 2003-01-28 | 0000-00-00 | No | No | Current |
| 63323-142-12 | 63323014212 | 1 VIAL, SINGLE-DOSE in 1 BOX (63323-142-12) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE | 2003-01-28 | 0000-00-00 | No | No | Current |